Skip to content

Intervention to Improve Follow-up of Abnormal Pap Test

Intervention to Improve Follow-up of Abnormal Pap Test

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00575510
Enrollment
341
Registered
2007-12-18
Start date
2005-10-31
Completion date
2012-04-30
Last updated
2018-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

unified theory of behavior, Pap test, cervical dysplasia, women's health

Brief summary

This project will examine whether a theory-based telephone intervention delivered by a nurse at the time women are informed of an abnormal Pap test result will increase adherence to follow-up recommendations.

Detailed description

Over 90% of deaths due to cervical cancer could be prevented with appropriate screening and treatment of precursor lesions. However, 20% to 70% of women in the United States who are told that their Papanicolaou (Pap) test was abnormal do not adhere to recommendations for follow-up care. This is a problem especially among minorities and women of lower socioeconomic status. The purpose of this part of the protocol is to test a theory-based intervention designed to improve adherence to follow-up among women who experience an abnormal Pap test. The intervention is a message, delivered over the telephone by a nurse, at the time Pap test results are given to patients. The investigators propose to randomize women who experience an abnormal Pap test to one of three groups: (1) targeted cultural belief + knowledge + importance message (intervention), (2) nontargeted belief + knowledge + importance (active control), or (3) standard care only (passive control). All three groups will receive standard care, which is to notify women by telephone of their abnormal results and provide instructions for follow-up. Women assigned to the intervention group also will receive a cultural belief component consistent with their racial/ethnic group, detailed information about follow-up procedures and the consequences of not returning for follow-up, and information regarding the importance of adhering to recommendations, particularly for low grade abnormalities. Women assigned to the active control group will receive a nontargeted belief component, plus procedural knowledge and a message on the importance of follow-up. Adherence to initial follow-up will be the primary outcome. Other behavioral outcomes, such as delayed care and completeness of care, also will be assessed over an 18-month interval by chart review. Additionally, the investigators will evaluate psychological outcomes including anxiety and distress. Finally, the investigators will examine the grade of abnormality (low versus high) as an effect modifier. The investigators anticipate that this research will result in an intervention that will improve several important behavioral and psychological outcomes related to abnormal Pap test results. The intervention is guided by a general integrative theoretical framework; therefore, this research will evaluate an intervention strategy that recognizes the importance of targeting culturally relevant beliefs about follow-up and key determinants of behavior (knowledge/skills, salience, environmental constraints) surrounding abnormal Pap test results. Ultimately, the objective of this research is to improve adherence to follow-up among low-income, minority women who are at particular risk of developing cervical cancer.

Interventions

BEHAVIORALIntervention

Multiple component intervention based in the unified theory of behavior

BEHAVIORALActive control

Partial intervention (full intervention minus cultural-specific component)

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Women aged 18 to 55 years who present to the University of Texas Medical Branch (UTMB) clinics for Pap testing.

Exclusion criteria

* Women who are currently pregnant * Have a current diagnosis of cervical cancer; or * Who are unable to understand English or Spanish.

Design outcomes

Primary

MeasureTime frameDescription
Adherence to Initial Follow-up (Yes/no)adherence rates at initial follow-up appointment, 2 weeks to 3 monthsAttendance at initial appointment to follow-up abnormal Pap test result

Secondary

MeasureTime frameDescription
State Trait Anxiety Inventory (STAI)-State Scale+ 7-30 days post-interventionState Anxiety short form measure (6-item); higher scores =worse outcomes (i.e., higher self-reported anxiety levels)

Countries

United States

Participant flow

Recruitment details

Face-to-face recruitment of women 18-55 years of age occurred in 6 University of Texas Medical Branch (UTMB) Regional and Maternal Child Health Program clinics from June 1, 2006-November 30, 2010. Recruitment was interrupted for a period ranging from 2 weeks to 6 months in several clinic sites due to landfall of hurricane Ike on September 13, 2008.

Pre-assignment details

6,179 women were eligible during the recruitment period. Of these, 876 declined participation, 4,671 had a normal Pap test result, 254 did not have a Pap test performed at their clinic visit, and 378 had an abnormal Pap test result and could be randomized. Of these, 90% (341/378)were randomized into the 3-arm trial.

Participants by arm

ArmCount
Intervention
Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
114
Active Control
nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
114
Standard Care Only
Clinical standard of care at time of study
113
Total341

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyClinic Called Patient777
Overall StudyLost to Follow-up469
Overall StudyPregnancy001
Overall StudyWithdrawal by Subject100

Baseline characteristics

CharacteristicInterventionActive ControlStandard Care OnlyTotal
Age, Continuous27 years
STANDARD_DEVIATION 7
28 years
STANDARD_DEVIATION 8
29 years
STANDARD_DEVIATION 8
28 years
STANDARD_DEVIATION 7
Region of Enrollment
United States
114 participants114 participants113 participants341 participants
Sex: Female, Male
Female
114 Participants114 Participants113 Participants341 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 1140 / 1140 / 113
serious
Total, serious adverse events
0 / 1140 / 1140 / 113

Outcome results

Primary

Adherence to Initial Follow-up (Yes/no)

Attendance at initial appointment to follow-up abnormal Pap test result

Time frame: adherence rates at initial follow-up appointment, 2 weeks to 3 months

ArmMeasureValue (NUMBER)
InterventionAdherence to Initial Follow-up (Yes/no)60 percentage of patients who were adherent
Active ControlAdherence to Initial Follow-up (Yes/no)54 percentage of patients who were adherent
Standard Care OnlyAdherence to Initial Follow-up (Yes/no)58 percentage of patients who were adherent
Secondary

State Trait Anxiety Inventory (STAI)-State Scale

State Anxiety short form measure (6-item); higher scores =worse outcomes (i.e., higher self-reported anxiety levels)

Time frame: + 7-30 days post-intervention

Population: Only participants who completed the post-test over the telephone 7-14 following notification of the abnormal Pap test result were asked these questions.

ArmMeasureValue (MEAN)Dispersion
InterventionState Trait Anxiety Inventory (STAI)-State Scale12 units on a scaleStandard Deviation 5
Active ControlState Trait Anxiety Inventory (STAI)-State Scale11 units on a scaleStandard Deviation 4
Standard Care OnlyState Trait Anxiety Inventory (STAI)-State Scale11 units on a scaleStandard Deviation 4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026